How does glucagon work in beta (beta blockers) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mechanism of Glucagon in Beta Blocker Overdose

Glucagon works in beta blocker overdose by bypassing the blocked beta-adrenergic receptors, activating hepatic adenyl cyclase directly to increase cardiac contractility, heart rate, and improve hemodynamics. 1

Physiological Mechanism

  • Glucagon is a vasoactive polypeptide that counteracts beta blocker effects by activating adenylate cyclase in the liver, promoting glycogenolysis and increasing cardiac function independently of beta-adrenergic receptors 2, 1
  • This bypass mechanism allows glucagon to increase heart rate and myocardial contractility even when beta receptors are blocked by overdosed beta blockers 3, 4
  • Glucagon works through a separate G-protein coupled receptor system that increases intracellular cAMP levels, similar to beta-receptor stimulation but through a different pathway 5
  • Recent clinical research confirms that high-dose glucagon produces significant hemodynamic effects regardless of beta-adrenergic blockade 6

Clinical Effects in Beta Blocker Overdose

  • Glucagon administration increases heart rate, systolic blood pressure, diastolic blood pressure, and cardiac output even in the presence of beta blockade 6
  • The American Heart Association recommends glucagon as a reasonable treatment (Class IIa recommendation) for bradycardia or hypotension due to beta blocker poisoning 2
  • Hemodynamic improvements typically include:
    • Increased heart rate (chronotropic effect)
    • Improved cardiac contractility (inotropic effect)
    • Reversal of atrioventricular conduction blocks 3, 5

Administration Protocol

  • The recommended dosing regimen is a bolus of 3-10 mg IV administered over 3-5 minutes 1
  • This should be followed by a continuous infusion of 3-5 mg/hour due to the transient effects of glucagon 1, 4
  • Continuous infusion may be preferable to repeated boluses as it provides more stable and potentially longer-lasting hemodynamic effects 6
  • The American College of Cardiology recommends glucagon as first-line therapy for symptomatic beta blocker-induced bradycardia 7

Limitations and Side Effects

  • Common side effects include nausea and vomiting, which occur in up to 80% of patients despite antiemetic pretreatment 6
  • Glucagon may temporarily increase blood pressure and heart rate in patients taking beta blockers, which requires monitoring in patients with coronary artery disease 8
  • Glucagon may lose its effectiveness in patients with depleted glycogen stores 7
  • When used with indomethacin, glucagon may lose its ability to raise blood glucose or even produce hypoglycemia 8

Place in Treatment Algorithm

  1. Initiate standard supportive measures (airway, breathing, circulation) 2
  2. For symptomatic bradycardia or hypotension due to beta blocker overdose:
    • Administer glucagon bolus (3-10 mg IV) followed by infusion (3-5 mg/h) 1, 7
    • Consider vasopressors for persistent hypotension 2
    • For refractory cases, high-dose insulin therapy is recommended (Class I recommendation) 2
    • Consider extracorporeal life support for shock refractory to pharmacological interventions 2

Evidence Quality and Limitations

  • Evidence supporting glucagon use in beta blocker overdose is primarily based on animal studies and case reports 5
  • The 2023 AHA guidelines give glucagon a Class IIa recommendation with level of evidence C-LD (limited data) 2
  • Recent randomized clinical trials confirm glucagon's hemodynamic effects regardless of beta blockade, supporting its use in overdose situations 6

Glucagon remains an important component in the management of beta blocker overdose, particularly for addressing bradycardia and hypotension, though high-dose insulin therapy has emerged as a first-line treatment for hypotension refractory to or used in conjunction with vasopressor therapy 2.

References

Guideline

Treatment of Beta Blocker Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006

Research

Glucagon therapy for beta-blocker overdose.

Drug intelligence & clinical pharmacy, 1984

Guideline

Treatment of Beta Blocker Induced Bradycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.